» Articles » PMID: 32586980

3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism

Overview
Journal Diabetes
Specialty Endocrinology
Date 2020 Jun 27
PMID 32586980
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating branched-chain amino acids (BCAAs) associate with insulin resistance and type 2 diabetes. 3-Hydroxyisobutyrate (3-HIB) is a catabolic intermediate of the BCAA valine. In this study, we show that in a cohort of 4,942 men and women, circulating 3-HIB is elevated according to levels of hyperglycemia and established type 2 diabetes. In complementary cohorts with measures of insulin resistance, we found positive correlates for circulating 3-HIB concentrations with HOMA2 of insulin resistance, as well as a transient increase in 3-HIB followed by a marked decrease after bariatric surgery and weight loss. During differentiation, both white and brown adipocytes upregulate BCAA utilization and release increasing amounts of 3-HIB. Knockdown of the 3-HIB-forming enzyme 3-hydroxyisobutyryl-CoA hydrolase decreases release of 3-HIB and lipid accumulation in both cell types. Conversely, addition of 3-HIB to white and brown adipocyte cultures increases fatty acid uptake and modulated insulin-stimulated glucose uptake in a time-dependent manner. Finally, 3-HIB treatment decreases mitochondrial oxygen consumption and generation of reactive oxygen species in white adipocytes, while increasing these measures in brown adipocytes. Our data establish 3-HIB as a novel adipocyte-derived regulator of adipocyte subtype-specific functions strongly linked to obesity, insulin resistance, and type 2 diabetes.

Citing Articles

Valine metabolite, 3-hydroxyisobutyrate, promotes lipid metabolism and cell proliferation in porcine mammary gland epithelial cells.

Che L, Liu L, Xu M, Fan Z, Niu L, Chen Y Front Nutr. 2025; 11():1524738.

PMID: 39867557 PMC: 11757131. DOI: 10.3389/fnut.2024.1524738.


Primary Roles of Branched Chain Amino Acids (BCAAs) and Their Metabolism in Physiology and Metabolic Disorders.

Bo T, Fujii J Molecules. 2025; 30(1.

PMID: 39795113 PMC: 11721030. DOI: 10.3390/molecules30010056.


Single-cell view and a novel protective macrophage subset in perivascular adipose tissue in T2DM.

Li J, Tian Z, Zhang T, Jin J, Zhang X, Xie P Cell Mol Biol Lett. 2024; 29(1):148.

PMID: 39627688 PMC: 11616190. DOI: 10.1186/s11658-024-00668-5.


Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes.

Antikainen A, Mutter S, Harjutsalo V, Thorn L, Groop P, Sandholm N Cardiovasc Diabetol. 2024; 23(1):425.

PMID: 39593124 PMC: 11590341. DOI: 10.1186/s12933-024-02512-8.


A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites.

Moya-Garzon M, Wang M, Li V, Lyu X, Wei W, Tung A Cell. 2024; 188(1):175-186.e20.

PMID: 39536746 PMC: 11724754. DOI: 10.1016/j.cell.2024.10.032.


References
1.
Lynch C, Adams S . Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014; 10(12):723-36. PMC: 4424797. DOI: 10.1038/nrendo.2014.171. View

2.
Svensson P, Lindberg K, M Hoffmann J, Taube M, Pereira M, Mohsen-Kanson T . Characterization of brown adipose tissue in the human perirenal depot. Obesity (Silver Spring). 2014; 22(8):1830-7. DOI: 10.1002/oby.20765. View

3.
Hu H, Jaskiewicz J, Harris R . Ethanol and oleate inhibition of alpha-ketoisovalerate and 3-hydroxyisobutyrate metabolism by isolated hepatocytes. Arch Biochem Biophys. 1992; 299(1):57-62. DOI: 10.1016/0003-9861(92)90243-p. View

4.
Ejarque M, Borlaug M, Vilarrasa N, Martinez-Perez B, Llaurado G, Megia A . Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery. Transl Res. 2017; 184:35-44.e4. DOI: 10.1016/j.trsl.2017.03.001. View

5.
Gudbrandsen O, Dankel S, Skumsnes L, Flolo T, Folkestad O, Nielsen H . Short-term effects of Vertical sleeve gastrectomy and Roux-en-Y gastric bypass on glucose homeostasis. Sci Rep. 2019; 9(1):14817. PMC: 6794318. DOI: 10.1038/s41598-019-51347-x. View